Upcoming Event: Cell and Gene Therapy World Conference 2017

Quad Technologies will be attending the Cell and Gene Therapy World Conference in Miami, FL on January 17-20, 2017. CEO Sean Kevlahan will be participating in the panel discussion, “Pharma, biotech, regulator and tool provider perspectives: When and where to introduce automation to your workflow? And what is the actual value in doing so?”  on January 18th. Please go to …

The Quad Team Reflects on 2016

As the year closes, the Quad team has taken a moment to reminisce their favorite and most memorable events of 2016.  Read more to see what each team member chose to highlight for 2016.

Quad Technologies Announces Poster Presentation at the 58th American Society of Hematology Annual Meeting

WOBURN, Mass.–(BUSINESS WIRE)–An abstract from Quad Technologies (”Quad”) has been accepted for presentation at the 58th annual American Society of Hematology meeting in San Diego, CA on December 3-6, 2016. The abstract is published on the ASH website at http://www.hematology.org/. In collaboration with an external partner focused on CAR-T cancer immunotherapy, the focus of the poster presentation is the use …

Quad Technologies Finalist for the 2016 BioProcess International Award

Quad Technologies has been nominated for a 2016 BioProcess International Award in the Emerging Company category.  Nominees in this category have been recognized for significant industry adoption with an opportunity to change the status quo.  This represents the best the industry has to offer and we are excited to be nominated alongside other innovative companies in the bioprocess industry.  The …

Upcoming Event: Boston Biotech Week 2016

We are happy to announce our attendance at the Cell and Gene Therapy Bioprocessing meeting during Boston Biotech Week, October 5-7, 2016.  Visit our team at Booth #1446 learn how MagCloudz cell isolation kits and methods yield highly viable cells for downstream research.

Quad Technologies: Launching a New Era in Cell Separation

Cell separation technologies and products from Quad Technologies address two of the greatest challenges in the advancement of cellular immune therapies today:  1) successfully and rapidly separating cells in the laboratory without threatening their viability, and 2) translating that success to a greater scale in clinical manufacturing applications. The company’s work is ushering in a new generation in cell separation that …

Quad Technologies Awarded a National Science Foundation STTR Phase I Grant

    Quad Technologies has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I grant to support research and development efforts addressing critical challenges associated with clinical cell processing.   The grant will support development of an Affinity Chromatographic Cell Sorting (AFFICS) System for sorting of multiple cell types from a heterogeneous mixture without the use …

Attracted to Start-Up Success: An Innovative Use of Polymer Coating for Cell Separation turns Northeastern Researchers into Entrepreneurs

Beginning in 2010, Chemical Engineer Professor Shashi Murthy, Ph.D, and his graduate students worked to develop a hydrogel coating that would adhere to individual cells, protecting them and allowing them to be separated from surrounding cells, blood and tissue. Eager to get their product- dubbed QuickGel™– into the hands of researchers, drug developers, and clinicians, the team filed for a …

Upcoming Event: American Association of Immunologists Annual Meeting 2016

Are you going to the American Association of Immunologists (AAI) Annual Meeting, May 13-17, 2016 in Seattle, WA? Visit our team at Booth #2120 to learn more about MagCloudz and Quickgel! We are proud to announce that we are a contributing sponsor! Stop by to pick up some marketing literature, learn about our new sample evaluation program, or just come by …

Development of a Novel Cell-Separation Platform: Discussion with Quad Technologies CEO Sean Kevlahan

Releasing and separating cells from surfaces and capture molecules are critical steps in cell therapy development. Research into such therapies as chimeric antigen receptor T cells (CAR-T) cancer therapies and stem-cell regenerative medicines demand the isolation and purification of viable and functional target cells. A number of cell-separation strategies can be used to produce such cells, but they are not …